Association of Cardiometabolic Multimorbidity with Risk of Late-life Depression: a Nationwide Twin Study

Overview

Journal Eur Psychiatry

Publisher Cambridge University Press

Specialty Psychiatry

Date 2024 Sep 25

PMID 39320861

Authors

Wenzhe Yang

Weiwei Li

Shuqi Wang

Xiuying Qi

Zhuoyu Sun

Abigail Dove

Weili Xu

Affiliations

Soon will be listed here.

Abstract

Background: Cardiometabolic diseases (CMDs) including heart disease, stroke, and type 2 diabetes have been individually linked to depression. However, their combined impact on depression risk is unclear. We aimed to examine the association between cardiometabolic multimorbidity and depression and explore the role of genetic background in this association.

Methods: Within the Swedish Twin Registry, 40,080 depression-free individuals (mean age 60 years) were followed for 18 years. Cardiometabolic multimorbidity was defined as having ≥2 CMDs. CMDs and depression were ascertained based on the National Patient Register. Cox regression was used to estimate the CMD-depression association in a classical cohort study design and a matched co-twin design involving 176 twin pairs. By comparing the associations between monozygotic and dizygotic co-twins, the contribution of genetic background was estimated.

Results: At baseline, 4809 (12.0%) participants had one CMD and 969 (2.4%) had ≥2 CMDs. Over the follow-up period, 1361 participants developed depression. In the classical cohort design, the multi-adjusted hazard ratios (95% confidence interval [CIs]) of depression were 1.52 (1.31-1.76) for those with one CMD and 1.83 (1.29-2.58) for those with ≥2 CMDs. CMDs had a greater risk effect on depression if they developed in mid-life (<60 years) as opposed to late life (≥60 years). In matched co-twin analysis, the CMD-depression association was significant among dizygotic twins (HR = 1.63, 95% CI, 1.02-2.59) but not monozygotic twins (HR = 0.90, 95% CI, 0.32-2.51).

Conclusions: Cardiometabolic multimorbidity is associated with an elevated risk of depression. Genetic factors may contribute to the association between CMDs and depression.

References

Liu S, Leone M, Ludvigsson J, Lichtenstein P, Gudbjornsdottir S, Landen M . Early-Onset Type 2 Diabetes and Mood, Anxiety, and Stress-Related Disorders: A Genetically Informative Register-Based Cohort Study. Diabetes Care. 2022; 45(12):2950-2956. PMC: 9862460. DOI: 10.2337/dc22-1053. View

Choi K, Stein M, Nishimi K, Ge T, Coleman J, Chen C . An Exposure-Wide and Mendelian Randomization Approach to Identifying Modifiable Factors for the Prevention of Depression. Am J Psychiatry. 2020; 177(10):944-954. PMC: 9361193. DOI: 10.1176/appi.ajp.2020.19111158. View

Champaneri S, Wand G, Malhotra S, Casagrande S, Golden S . Biological basis of depression in adults with diabetes. Curr Diab Rep. 2010; 10(6):396-405. DOI: 10.1007/s11892-010-0148-9. View

Rokita K, Dauvermann M, Donohoe G . Early life experiences and social cognition in major psychiatric disorders: A systematic review. Eur Psychiatry. 2018; 53:123-133. DOI: 10.1016/j.eurpsy.2018.06.006. View

. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022; 9(2):137-150. PMC: 8776563. DOI: 10.1016/S2215-0366(21)00395-3. View

Feng H, Chien W, Cheng W, Chung C, Cheng S, Tzeng W . Risk of anxiety and depressive disorders in patients with myocardial infarction: A nationwide population-based cohort study. Medicine (Baltimore). 2016; 95(34):e4464. PMC: 5400317. DOI: 10.1097/MD.0000000000004464. View

Linden T, Blomstrand C, Skoog I . Depressive disorders after 20 months in elderly stroke patients: a case-control study. Stroke. 2007; 38(6):1860-3. DOI: 10.1161/STROKEAHA.106.471805. View

Katon W . Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci. 2011; 13(1):7-23. PMC: 3181964. View

Lichtenstein P, de Faire U, Floderus B, Svartengren M, Svedberg P, Pedersen N . The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. J Intern Med. 2002; 252(3):184-205. DOI: 10.1046/j.1365-2796.2002.01032.x. View

10.

Kelishadi R, Poursafa P . A review on the genetic, environmental, and lifestyle aspects of the early-life origins of cardiovascular disease. Curr Probl Pediatr Adolesc Health Care. 2014; 44(3):54-72. DOI: 10.1016/j.cppeds.2013.12.005. View

11.

Taylor W, Aizenstein H, Alexopoulos G . The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry. 2013; 18(9):963-74. PMC: 3674224. DOI: 10.1038/mp.2013.20. View

12.

Schaakxs R, Comijs H, van der Mast R, Schoevers R, Beekman A, Penninx B . Risk Factors for Depression: Differential Across Age?. Am J Geriatr Psychiatry. 2017; 25(9):966-977. DOI: 10.1016/j.jagp.2017.04.004. View

13.

Gong L, Ma T, He L, Lin G, Zhang G, Cheng X . Association between single and multiple cardiometabolic diseases and depression: A cross-sectional study of 391,083 participants from the UK biobank. Front Public Health. 2022; 10:904876. PMC: 9386503. DOI: 10.3389/fpubh.2022.904876. View

14.

Herrman H, Patel V, Kieling C, Berk M, Buchweitz C, Cuijpers P . Time for united action on depression: a Lancet-World Psychiatric Association Commission. Lancet. 2022; 399(10328):957-1022. DOI: 10.1016/S0140-6736(21)02141-3. View

15.

Han Y, Hu Y, Yu C, Guo Y, Pei P, Yang L . Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study. Eur Heart J. 2021; 42(34):3374-3384. PMC: 8423468. DOI: 10.1093/eurheartj/ehab413. View

16.

Yang W, Wang Z, Li X, Qi X, Zhang L, Pan K . Association of depression with mortality in nationwide twins: The mediating role of dementia. Eur Psychiatry. 2022; 65(1):e63. PMC: 9641650. DOI: 10.1192/j.eurpsy.2022.34. View

17.

Kivimaki M, Kuosma E, Ferrie J, Luukkonen R, Nyberg S, Alfredsson L . Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health. 2017; 2(6):e277-e285. PMC: 5463032. DOI: 10.1016/S2468-2667(17)30074-9. View

18.

Papazacharias A, Logroscino G, Barulli M, Nardini M . Late life depression and late onset depression: are the same clinical and pathopsysiological picture?. Psychiatr Danub. 2010; 22 Suppl 1:S108-10. View

19.

Tai X, Veldsman M, Lyall D, Littlejohns T, Langa K, Husain M . Cardiometabolic multimorbidity, genetic risk, and dementia: a prospective cohort study. Lancet Healthy Longev. 2022; 3(6):e428-e436. PMC: 9184258. DOI: 10.1016/S2666-7568(22)00117-9. View

20.

Semenkovich K, Brown M, Svrakic D, Lustman P . Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs. 2015; 75(6):577-87. DOI: 10.1007/s40265-015-0347-4. View